A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
A study to compare the change in cognitive performance and psychological status of patients with spasticity due to Multiple Sclerosis when treated with Sativex or placebo, added to existing anti-spasticity therapy over a period of 48 weeks. Secondary objectives were to evaluate the effect of Sativex on mood and spasticity and to assess the safety and tolerability of Sativex.
Epistemonikos ID: c2d58f3c53b9d70d33a18614911f6706c5b3c090
First added on: Apr 23, 2019